Genomics Sales Representative (Inside Sales - Greater Boston Remote)
IlluminaFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Florida, United States
Key technologies and capabilities for this role
Common questions about this position
Candidates need a B.S. in life science, biology, business, or marketing, with an MBA preferred, and 3+ years of direct account management experience in a molecular diagnostic field.
The role requires proven ability in consultative selling of molecular diagnostic solutions, in-depth knowledge of oncology diagnostics reimbursement, strong communication and project management skills, advanced presentation skills, and proficiency in Microsoft Office and Salesforce.
The role involves territory management in North Florida, including budgets and travel, focusing on major U.S. cancer centers, health systems, and community practices, indicating significant travel within the assigned territory.
Tempus emphasizes representing the company culture with integrity, respect, and trust to external and internal stakeholders.
Strong candidates have experience engaging executive-level stakeholders, knowledge of molecular diagnostics and MRD testing, consultative selling skills, and the ability to develop cross-functional relationships with minimal direction.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.